Sen. Bernie Sanders, I-Vt., says the first question he is going to ask Novo Nordisk’s CEO at a Senate committee hearing in September is why the drugmaker charges up to 10 or 15 times more for Ozempic and Wegovy in the United States, compared to other countrie…
Read More